Related Experiment Video
Updated: Apr 23, 2026
11:54
Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues
Published on: October 20, 2019
8.3K
Molecular diagnostics and therapeutics for ectopic pregnancy
Stephen Tong1, Monika M Skubisz2, Andrew W Horne3
1Translational Obstetrics Group, Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, 163 Studley Rd, Heidelberg 3084, Australia stong@unimelb.edu.au.
Molecular Human Reproduction
|September 19, 2014
Summary
Early diagnosis and treatment of ectopic pregnancy are crucial. Research explores molecular biomarkers for diagnostics and targeted therapies like gefitinib and methotrexate, showing promise for improved ectopic pregnancy management.
Area of Science:
- Gynecology and Reproductive Medicine
- Molecular Diagnostics and Therapeutics
- Biomarker Discovery
Background:
- Ectopic pregnancy is a life-threatening gynecological emergency requiring prompt diagnosis and treatment.
- Current diagnostic methods, including ultrasound, can be limited in cases of pregnancy of unknown location.
- Existing treatments for ectopic pregnancy have limitations, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review the literature on molecularly targeted diagnostics and therapeutics for ectopic pregnancy.
- To explore the potential of blood-based biomarkers for early and accurate ectopic pregnancy detection.
- To evaluate emerging molecularly targeted therapies for ectopic pregnancy treatment.
Main Methods:
- Literature review of studies investigating molecular targets for ectopic pregnancy diagnostics and therapeutics.
- Analysis of biological themes related to reproduction, including Fallopian tube function, embryo growth, and angiogenesis.
- Examination of preclinical and early human trial data for combination gefitinib and methotrexate therapy.
Main Results:
- No definitive sensitive and specific blood-based biomarker for ectopic pregnancy has been identified to date.
- Potential diagnostic approaches include improved platform technologies, multi-modal biomarkers, or advanced imaging (ultrasound, MRI).
- Combination gefitinib and methotrexate demonstrates high efficacy in preclinical studies for inducing placental cell death, outperforming methotrexate alone.
Conclusions:
- While a definitive biomarker is pending, advancements in diagnostics and imaging may improve early detection of ectopic pregnancy.
- Combination gefitinib and methotrexate shows significant promise as a novel, effective medical treatment for various types of ectopic pregnancies.
- Further large-scale clinical trials are needed to confirm the efficacy and safety of combination gefitinib and methotrexate for ectopic pregnancy.
